Skip to main content
Top
Published in: Clinical and Experimental Nephrology 1/2014

01-02-2014 | Original Article

Subclinical non-autoimmune hypothyroidism in children with steroid resistant nephrotic syndrome

Authors: Kanika Kapoor, Abhijeet Saha, N. K. Dubey, Parul Goyal, C. P. Suresh, Vinita Batra, Ashish Dutt Upadhayay

Published in: Clinical and Experimental Nephrology | Issue 1/2014

Login to get access

Abstract

Background

Thyroid status has not been studied well in children with steroid resistant nephrotic syndrome (SRNS).

Methods

In this cross sectional study we recruited 20 children aged 1–16 years with SRNS and similar number of controls. Serum levels of FT3, FT4 and TSH were measured in all the subjects. Overt hypothyroidism was defined as low FT4 (normal values: 0.7–2.0 ng/mL) and elevated serum TSH above reference values (0.45–4.5 mIU/L). Subclinical hypothyroidism (SH) was defined as an elevation in serum TSH with a normal serum FT4 concentration. The primary outcome measure was serum levels of FT3, FT4 and TSH in children with SRNS.

Results

Thirty per cent of the children (n = 6) with SRNS had non-autoimmune subclinical hypothyroidism (2 children each with grade I, II and III). Children with SRNS had a median TSH value [3.9 mIU/L (0.5–13)] within normal range, but levels were high as compared to controls. Out of 6 children with SH, 3 were in partial remission, 3 were in complete remission. The TSH levels normalized on thyroxine supplementation in grades II and III subclinical hypothyroidism.

Conclusion

Subclinical non-autoimmune hypothyroidism is present in a significant proportion of children with SRNS despite partial or complete remission. Thyroid profile should be evaluated routinely in this subset of patients.
Literature
1.
2.
3.
4.
go back to reference Feinstein EI, Kaptein EM, Nicoloff JT, Massry SG. Thyroid function in patients with nephrotic syndrome and normal renal function. Am J Nephrol. 1982;2:70–6.PubMedCrossRef Feinstein EI, Kaptein EM, Nicoloff JT, Massry SG. Thyroid function in patients with nephrotic syndrome and normal renal function. Am J Nephrol. 1982;2:70–6.PubMedCrossRef
5.
go back to reference Oyemade OA, Lukanmbi FA, Osotimehin BO, Dada OA. Biochemical hypothyroidism in Nigerian children with nephrotic syndrome. Ann Trop Paediatr. 1983;3(2):93–6.PubMed Oyemade OA, Lukanmbi FA, Osotimehin BO, Dada OA. Biochemical hypothyroidism in Nigerian children with nephrotic syndrome. Ann Trop Paediatr. 1983;3(2):93–6.PubMed
6.
go back to reference Ito S, Kano K, Ando T, Ichimura T. Thyroid function in children with nephrotic syndrome. Pediatr Nephrol. 1994;8:412–5.PubMedCrossRef Ito S, Kano K, Ando T, Ichimura T. Thyroid function in children with nephrotic syndrome. Pediatr Nephrol. 1994;8:412–5.PubMedCrossRef
7.
go back to reference Afroz S, Khan AH, Roy DK. Thyroid function in children with nephrotic syndrome. Mymensingh Med J. 2011;20(3):407–11.PubMed Afroz S, Khan AH, Roy DK. Thyroid function in children with nephrotic syndrome. Mymensingh Med J. 2011;20(3):407–11.PubMed
8.
9.
go back to reference Kacer M, Whyte DA, Boydstun I. Congenital nephrotic syndrome and persistent hypothyroidism after bilateral nephrectomy. J Pediatr Endocrinol Metab. 2008;21(6):597–601.PubMed Kacer M, Whyte DA, Boydstun I. Congenital nephrotic syndrome and persistent hypothyroidism after bilateral nephrectomy. J Pediatr Endocrinol Metab. 2008;21(6):597–601.PubMed
11.
go back to reference Indian Society of Pediatric Nephrology. Management of steroid resistant nephrotic syndrome. Indian Pediatr. 2009;46:35–47. Indian Society of Pediatric Nephrology. Management of steroid resistant nephrotic syndrome. Indian Pediatr. 2009;46:35–47.
12.
go back to reference Nananda FC, Martin IS, Gilbert HD. Subclinical thyroid disease: clinical applications. JAMA. 2004;291:239–43.CrossRef Nananda FC, Martin IS, Gilbert HD. Subclinical thyroid disease: clinical applications. JAMA. 2004;291:239–43.CrossRef
13.
go back to reference Castro-Gago M, Novo-Rodríguez MI, Gómez-Lado C, Rodríguez-García J, Rodríguez-Segade S, Eirís-Puñal J. Evolution of subclinical hypothyroidism in children treated with antiepileptic drugs. Pediatr Neurol. 2007;37(6):426–30.PubMedCrossRef Castro-Gago M, Novo-Rodríguez MI, Gómez-Lado C, Rodríguez-García J, Rodríguez-Segade S, Eirís-Puñal J. Evolution of subclinical hypothyroidism in children treated with antiepileptic drugs. Pediatr Neurol. 2007;37(6):426–30.PubMedCrossRef
14.
go back to reference Rapa A, Monzani A, Moia S, Bellone S, Petri A, Teofoli F, et al. Subclinical hypothyroidism in children and adolescents: a wide range of clinical, biochemical, and genetic factors involved. J Clin Endocrinol Metab. 2009;94:2414–20.PubMedCrossRef Rapa A, Monzani A, Moia S, Bellone S, Petri A, Teofoli F, et al. Subclinical hypothyroidism in children and adolescents: a wide range of clinical, biochemical, and genetic factors involved. J Clin Endocrinol Metab. 2009;94:2414–20.PubMedCrossRef
15.
go back to reference Dagan A, Cleper R, Krause I, Blumenthal D, Davidovits M. Hypothyroidism in children with steroid-resistant nephrotic syndrome. Nephrol Dial Transpl. 2012;27:2171–5.CrossRef Dagan A, Cleper R, Krause I, Blumenthal D, Davidovits M. Hypothyroidism in children with steroid-resistant nephrotic syndrome. Nephrol Dial Transpl. 2012;27:2171–5.CrossRef
16.
go back to reference Enrı′quez R, Sirvent AE, Amoro′s F, Andrada E, Cabezuelo JB, Reyes A. IgA nephropathy and autoimmune thyroiditis. Clin Nephrol. 2002;57:406–7. Enrı′quez R, Sirvent AE, Amoro′s F, Andrada E, Cabezuelo JB, Reyes A. IgA nephropathy and autoimmune thyroiditis. Clin Nephrol. 2002;57:406–7.
17.
go back to reference Illies F, Wingen AM, Bald M, Hoyer PF. Autoimmune thyroiditis in association with membranous nephropathy. J Pediatr Endocrinol Met. 2004;17:99–104. Illies F, Wingen AM, Bald M, Hoyer PF. Autoimmune thyroiditis in association with membranous nephropathy. J Pediatr Endocrinol Met. 2004;17:99–104.
18.
go back to reference Iwaoka T, Umeda T, Nakayama M, Shimada T, Fujii Y, Miura F, et al. A case of membranous nephropathy associated with thyroid antigens. Jpn J Med. 1982;21:29–34.PubMedCrossRef Iwaoka T, Umeda T, Nakayama M, Shimada T, Fujii Y, Miura F, et al. A case of membranous nephropathy associated with thyroid antigens. Jpn J Med. 1982;21:29–34.PubMedCrossRef
19.
go back to reference Saha A, Bagri N, Mehera N, Dubey NK, Batra V. Membranoproliferative glomerulonephritis associated with autoimmune thyroiditis. J PediatrEndocr Met. 2011;24(9–10):789–92. Saha A, Bagri N, Mehera N, Dubey NK, Batra V. Membranoproliferative glomerulonephritis associated with autoimmune thyroiditis. J PediatrEndocr Met. 2011;24(9–10):789–92.
20.
go back to reference Valentin M, Bueno B, Gutierrez E, Martinez A, Gonzalez E, Espejo B, et al. Membranoproliferative glomerulonephritis associated with autoimmune thyroiditis. Nefrologia. 2004;24:43–8.PubMed Valentin M, Bueno B, Gutierrez E, Martinez A, Gonzalez E, Espejo B, et al. Membranoproliferative glomerulonephritis associated with autoimmune thyroiditis. Nefrologia. 2004;24:43–8.PubMed
23.
go back to reference Gilles R, Heijer MD, Ross AH. Thyroid function in patients with proteinuria. Neth J Med. 2008;66(11):483–5.PubMed Gilles R, Heijer MD, Ross AH. Thyroid function in patients with proteinuria. Neth J Med. 2008;66(11):483–5.PubMed
24.
go back to reference Khurana M, Traum AZ, Aivado M, Wells MP, Guerrero M, Grall F, et al. Urine proteomic profiling of pediatric nephrotic syndrome. Pediatr Nephrol. 2006;21:1257–65.PubMedCentralPubMedCrossRef Khurana M, Traum AZ, Aivado M, Wells MP, Guerrero M, Grall F, et al. Urine proteomic profiling of pediatric nephrotic syndrome. Pediatr Nephrol. 2006;21:1257–65.PubMedCentralPubMedCrossRef
26.
go back to reference Alkemade A, Unmehopa UA, Wiersinga WM, Swaab DF, Fliers E, et al. Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus. J Clin Endocrinol Metab. 2005;90(1):323–7.PubMedCrossRef Alkemade A, Unmehopa UA, Wiersinga WM, Swaab DF, Fliers E, et al. Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus. J Clin Endocrinol Metab. 2005;90(1):323–7.PubMedCrossRef
27.
go back to reference Kaplowitz PB. Subclinical Hypothyroidism in children: normal variation or sign of a failing thyroid gland? Int J Pediatr Endocrinol 2010;2010:281453. Kaplowitz PB. Subclinical Hypothyroidism in children: normal variation or sign of a failing thyroid gland? Int J Pediatr Endocrinol 2010;2010:281453.
28.
go back to reference O’Grady MJ, Cody D. Subclinical hypothyroidism in childhood. Arch Dis Child. 2011;96:280–4. O’Grady MJ, Cody D. Subclinical hypothyroidism in childhood. Arch Dis Child. 2011;96:280–4.
29.
go back to reference Shin DH, Lee MJ, Seung JK. Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 2012;97:2732–40.PubMedCrossRef Shin DH, Lee MJ, Seung JK. Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 2012;97:2732–40.PubMedCrossRef
30.
go back to reference Ittermann T, Thamm M, Wallaschofski H, Rettig R, Volzke H. Serum thyroid-stimulating hormone levels are associated with blood pressure in children and adolescents. J Clin Endocrinol Metab. 2012;97(3):828–34.PubMedCrossRef Ittermann T, Thamm M, Wallaschofski H, Rettig R, Volzke H. Serum thyroid-stimulating hormone levels are associated with blood pressure in children and adolescents. J Clin Endocrinol Metab. 2012;97(3):828–34.PubMedCrossRef
31.
go back to reference Carracio N, Ferrannini E, Monzani F. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab. 2002;87(4):1533–8.CrossRef Carracio N, Ferrannini E, Monzani F. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab. 2002;87(4):1533–8.CrossRef
32.
go back to reference Lekakis J, Papamichael C, Alevizaki M, Piperingos G, Marafelia P, Mantzos J, et al. Flow mediated endothelium-dependent vasodilatation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high normal serum thyrotropin (TSH) values. Thyroid. 1997;7:411–4.PubMedCrossRef Lekakis J, Papamichael C, Alevizaki M, Piperingos G, Marafelia P, Mantzos J, et al. Flow mediated endothelium-dependent vasodilatation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high normal serum thyrotropin (TSH) values. Thyroid. 1997;7:411–4.PubMedCrossRef
Metadata
Title
Subclinical non-autoimmune hypothyroidism in children with steroid resistant nephrotic syndrome
Authors
Kanika Kapoor
Abhijeet Saha
N. K. Dubey
Parul Goyal
C. P. Suresh
Vinita Batra
Ashish Dutt Upadhayay
Publication date
01-02-2014
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 1/2014
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-013-0800-1

Other articles of this Issue 1/2014

Clinical and Experimental Nephrology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.